Surgical management of distant metastases

Surgical Oncology Clinics of North America
D W Ollila, Abigail S Caudle

Abstract

Although the location of metastases is of prognostic importance in stage IV melanoma, as seen in the revised AJCC staging classification system and other studies, certain guiding principles apply to patients who have any stage IV disease. Close follow-up of any patient who has melanoma may identify surgically resectable metastatic disease, although this method is controversial. Components of this monitoring may include careful questioning to determine symptoms, such as cough, abdominal pain, or headaches; physical examination for evidence of skin, soft tissue, and lymph node metastases; and screening tools, such as radiographs and laboratory tests. Identifying patients who have metastatic disease at the earliest stage possible is crucial for surgical resection to be an option. Patients should also be thoughtfully evaluated for the possibility of a complete surgical re-section. Complete metastectomy, regardless of the anatomic site, confers survival advantages not seen with other treatment modalities. This aggressive surgical approach should be tempered with the knowledge that incomplete resections put patients at increased risk without any proven survival benefit, and should be reserved only for palliation of symptoms. Systemic...Continue Reading

References

Aug 1, 1991·The Annals of Thoracic Surgery·L A GorensteinJ A Roth
Jun 1, 1991·Archives of Surgery·J S MarkowitzA B Cosimi
Nov 15, 1990·Cancer·K BregaW Wittenberg
Aug 17, 1989·The New England Journal of Medicine·E D CrawfordP J Goodman
Jul 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·L TafraD L Morton
Sep 1, 1996·Archives of Surgery·D W OllilaD L Morton
Jan 9, 1999·Journal of Surgical Oncology·D W OllilaD L Morton
May 29, 2001·World Journal of Surgery·H GutmanC M Balch
Apr 17, 2002·International Journal of Radiation Oncology, Biology, Physics·Cheng YuZbigniew Petrovich
Jul 8, 2003·Onkologie·C Garbe, D Schadendorf
Sep 5, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R ParidaensUNKNOWN European Organization for the Research and Treatment of Cancer (EORTC)- Investigational Drug Branch for Breast Cancer (IDBB
Jun 1, 1964·Archives of Surgery·T K DASGUPTA, R D BRASFIELD
Mar 31, 2004·The Journal of Thoracic and Cardiovascular Surgery·Masaki AnrakuUNKNOWN Metastatic Lung Tumor Study Group of Japan
Apr 13, 2004·Current Opinion in Oncology·Sandra L Wong, Daniel G Coit
Apr 13, 2004·Current Opinion in Oncology·Ahmad A Tarhini, Sanjiv S Agarwala
May 1, 2004·Surgery·Hiroshi ImamuraMasatoshi Makuuchi
Jun 30, 2004·The Annals of Thoracic Surgery·Masayoshi InoueUNKNOWN Thoracic Surgery Study Group of Osaka University
Sep 24, 2004·Archives of Surgery·Richard EssnerDonald L Morton
Oct 8, 2004·The New England Journal of Medicine·Daniel P PetrylakE David Crawford
Jun 22, 2005·European Urology·Hans-Stefan HofmannRolf-Edgar Silber

❮ Previous
Next ❯

Citations

Sep 16, 2010·Current Treatment Options in Neurology·Steven F Powell, Arkadiusz Z Dudek
Jan 19, 2012·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·B SzynglarewiczR Matkowski
Aug 23, 2011·Journal of Surgical Oncology·Vernon K SondakRagini Kudchadkar
Jan 13, 2015·Future Oncology·Peter Hersey, Kavitha Gowrishankar
Feb 18, 2010·Faraday Discussions·Svetlana BaoukinaD Peter Tieleman
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert D TimmermanL Chinsoo Cho
May 25, 2011·Nature Reviews. Clinical Oncology·Simon S LoRobert D Timmerman
May 17, 2013·American Journal of Clinical Dermatology·Marta BatusHoward L Kaufman
Sep 5, 2008·Nuclear Medicine Communications·Ivan A Ho ShonJohn F Thompson
Jul 4, 2008·Cancer Control : Journal of the Moffitt Cancer Center·James M McLoughlinLawrence B Berk
Nov 1, 2014·Melanoma Management·Peter HerseyRichard Scolyer
Feb 13, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Delphine DenoyerRodney J Hicks
Feb 28, 2008·Current Opinion in Oncology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Surgical Oncology
D W OllilaDonald L Morton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
O EtonR S Benjamin
The Surgical Clinics of North America
Richard Essner
© 2022 Meta ULC. All rights reserved